Advancing the Management of Cholestatic Liver Disease: Optimizing Treatment Pathways and Emerging Therapies
In this activity, experts in adult and paediatric hepatology and gastroenterology explore practical strategies and evidence-based tools to diagnose and facilitate tailored treatment decision-making for primary biliary cholangitis (PBC) and progressive familial intrahepatic cholestasis (PFIC).
Supported by: Ipsen Biopharmaceuticals, Inc.
Organized by: PeerVoice
CME Provider: USF Health
Important Note: Continuing education credits for Satellite Symposia are offered by the sponsoring organizations. These sessions are not accredited by AASLD.